NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 65 filers reported holding NEOS THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $136,000 | -40.6% | 90,202 | -41.8% | 0.00% | -33.3% |
| Q3 2019 | $229,000 | +69.6% | 155,062 | +47.9% | 0.01% | +100.0% |
| Q2 2019 | $135,000 | +13.4% | 104,841 | +129.4% | 0.00% | 0.0% |
| Q1 2019 | $119,000 | +197.5% | 45,706 | +89.1% | 0.00% | +200.0% |
| Q4 2018 | $40,000 | -99.0% | 24,171 | -93.9% | 0.00% | -98.8% |
| Q4 2017 | $3,931,000 | – | 395,103 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
| Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
| DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
| Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
| J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
| Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |